Target intelligence / Profile preview

Actinide ion

Molecular classification
Other (actinide ions are elemental metal cations, not biomolecular targets, receptors, enzymes, etc.)
01

Overview

Actinide ions refer to the cationic forms of the elements in the actinide series (atomic numbers 89–103, actinium through lawrencium), which are heavy, radioactive metals with partially filled 5f electron shells. Actinides frequently form multiple positive ions in solution (commonly +3, +4, +5, or +6 oxidation states) and have a strong tendency to form coordination complexes. These ions are highly electropositive and react readily with water, acids, and organic/inorganic ligands, and are distinguished by large ionic radii, high charge density, and strong radioactive decay. Their presence in the environment is of concern due to potent radiochemistry and toxicity. Unlike classic drug targets (such as receptors, enzymes, or transporters), actinide ions are not molecules with biological function in human physiology and are not recognized as therapeutic targets. Notes on data quality: - “Actinide ions” is not a canonical biological drug target, but a plural, generic chemical grouping of metal ions; it does not refer to a receptor, enzyme, or similar therapeutically actionable entity. - The entry is likely incorrect, overly generic, or missing sufficient specificity. For example, “Uranium ion” or “Plutonium ion” would more accurately specify a particular actinide in a defined oxidation state. - Actinide ions do not serve as endogenous molecular targets in therapeutics; rather, therapies and chelators are developed to bind and remove actinide ions in cases of poisoning, and they are of major interest in nuclear medicine, radiochemistry, and environmental health—but not in classic target-based drug discovery. Summary: “Actinide ion” is not a receptor, enzyme, transporter, or other standard molecular drug target. It refers collectively to the cations of radioactive actinide elements, which are notable for their radiological risk and chemical reactivity, but do not have canonical biological functions or typical roles in disease as molecular targets. Their main relevance is in the context of nuclear health and environmental toxicology.

Other names
actinide cationactinide metal ionAn^3+^actinoid ion
02

Safety considerations

High radioactivity (serious radiological risks)Heavy metal toxicity (toxic effects similar to other heavy metals)Environmental contamination concerns

Beyond the preview

Go deeper on Actinide ion.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Actinide ion.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call